Cardiology

New brain-imaging software identifies people who might benefit from treatment long after the time it has generally been considered helpful.

CRISPR is a revolutionary gene-editing tool, but it’s not without risk

Babies with rare genetic disorders have chance for longer lives

Mechanical heart valves are often safer than natural tissue for mitral valve replacement until age 70.

Stanford’s heart transplant breakthrough precipitated years of protocol advances

The enormity of the first U.S. adult heart transplant

It’s not just for gene therapy

Caution surrounds the use of animals to solve donor shortages

Using heart patients' own tissue to repair damaged valves

A health-care revolution in the making